Search results for: “keytruda”
-
Blog
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
Blog
FDA approves Keytruda combo for first-line lung cancer treatment
Patients in the U.S. who have advanced nonsquamous non-small cell lung cancer can now receive Keytruda as…
-
Blog
Pembrolizumab (Keytruda®) Approved as First-Line Option for Lung Cancer
Anti-PD-1 checkpoint antibody is the only immunotherapy approved for first-line treatment for lung cancer patients.
-
Blog
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer
New hope now exists for patients with advanced head and neck cancer.
-
Blog
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma
The decision makes pembrolizumab the second PD-1-blocking drug to receive approval in Europe.
-
Page
Immunomodulators
Immunomodulators Immunomodulators: Checkpoint Inhibitors, Cytokines, Agonists, and Adjuvants Reviewed by: Jason Luke, MD, FACPUniversity of Pittsburgh Medical… -
Page
Uterine (Endometrial) Cancer
Immunotherapy: For Uterine Cancer What Makes Immunotherapy for Uterine Cancer a Promising Treatment? Reviewed by: Dmitriy Zamarin,… -
Page
Stomach Cancer
Immunotherapy: For Stomach Cancer What Makes Immunotherapy for Stomach Cancer a Promising Treatment? Reviewed by: Joseph Chao,… -
Page
Skin Cancer
Immunotherapy: For Skin Cancer What Makes Immunotherapy for Skin Cancer a Promising Treatment? Reviewed by: Jedd Wolchok,…